Safe Implant Technology ApS: Financial statements 2023
CVR: 38969153
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -194,943 and a net result of DKK -194,735 compared with DKK -6,817 the year before. Equity in the 2023 report amounted to DKK -167,893.
- Gross Profit
- DKK -194,943
- Profit/Loss
- DKK -194,735
- Equity
- DKK -167,893
- Total Assets
- DKK 1,584,050
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -195 t. | -195 t. | -168 t. | 0 |
| 2022 | - | -6 t. | -7 t. | 27 t. | 0 |
| 2021 | - | -7 t. | -7 t. | 34 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 44 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Safe Implant Technology ApS has published its annual report for 2022. Gross profit came to DKK -6,485, and the net result was DKK -6,817.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.